Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YMN107
- Development stage
- Phase 1
- Lead developer
- West China Hospital of Sichuan University
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
**YMN107** is an investigational, GM-CSF-transfected irradiated tumor-cell therapeutic cancer vaccine developed by West China Hospital. It is part of a platform of personalized cellular vaccines comprising irradiated tumor cells plus stromal cells isolated from adjacent non-cancerous tissue or tumor tissue and an unspecified adjuvant. The vaccine is intended to provide a broad repertoire of tumor-associated antigens while GM-CSF expression is intended to enhance antitumor immune priming. YMN107 is being evaluated as a subcutaneous first-in-human Phase 1 treatment for advanced malignant solid tumors. ([synapse.patsnap.com](https://synapse.patsnap.com/drug/11b9428af42f4fd7887ca9621331479f))
- Other names
- YMN 107YMN107YMN-107YMN107 tumor cell vaccineYMN-107 tumor cell vaccineYMN 107 tumor cell vaccine
02
Targets
CSF2R (Granulocyte-macrophage colony-stimulating factor receptor)
Beyond the preview
Go deeper on YMN107.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YMN107.